Ray Dalio's NEO Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 91,190 shares of NeoGenomics, Inc. (NEO) worth $676,630, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in NEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 91,190 shares. Largest reduction occurred in Q4 2023, reducing 118,513 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's NeoGenomics (NEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeoGenomics (NEO) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +91,190 | New Buy | 91,190 | $7.42 |
| Q1 2025 | -14,397 | Sold Out | 0 | $0.00 |
| Q4 2024 | -35,957 | Reduce 71.41% | 14,397 | $16.48 |
| Q3 2024 | -12,374 | Reduce 19.73% | 50,354 | $14.75 |
| Q2 2024 | +38,121 | Add 154.92% | 62,728 | $13.87 |
| Q1 2024 | -5,226 | Reduce 17.52% | 24,607 | $15.72 |
| Q4 2023 | -118,513 | Reduce 79.89% | 29,833 | $16.18 |
| Q3 2023 | +21,755 | Add 17.19% | 148,346 | $12.30 |
| Q2 2023 | -6,836 | Reduce 5.12% | 126,591 | $16.07 |
| Q1 2023 | +133,427 | New Buy | 133,427 | $17.41 |
Ray Dalio's NeoGenomics Investment FAQs
Ray Dalio first purchased NeoGenomics, Inc. (NEO) in Q1 2023, acquiring 133,427 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held NeoGenomics, Inc. (NEO) for 10 quarters since Q1 2023.
Ray Dalio's largest addition to NeoGenomics, Inc. (NEO) was in Q1 2023, adding 133,427 shares worth $2.32 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 91,190 shares of NeoGenomics, Inc. (NEO), valued at approximately $676,630.
As of the Q1 2026 filing, NeoGenomics, Inc. (NEO) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in NeoGenomics, Inc. (NEO) was 148,346 shares, as reported at the end of Q3 2023.